Octave Bioscience has raised $35.6 million in funding to continue marketing its multiple sclerosis (MS) disease activity test and accelerate the development of a similar tool for Parkinson’s disease. The […]
The post New blood test for MS receives major commercialization funding appeared first on Multiple Sclerosis News Today.
Source: multiplesclerosisnewstoday.com